
Ram N. Kackar
Examiner (ID: 11212, Phone: (571)272-1436 , Office: P/2615 )
| Most Active Art Unit | 1716 |
| Art Unit(s) | 1792, 2615, 1763, 1716 |
| Total Applications | 923 |
| Issued Applications | 350 |
| Pending Applications | 78 |
| Abandoned Applications | 519 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5993043
[patent_doc_number] => 20110014696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'METHOD FOR PRODUCING DENDRITIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/841064
[patent_app_country] => US
[patent_app_date] => 2010-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10109
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014696.pdf
[firstpage_image] =>[orig_patent_app_number] => 12841064
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/841064 | Method for producing dendritic cells | Jul 20, 2010 | Issued |
Array
(
[id] => 8571192
[patent_doc_number] => 08337833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Methods of improving central nervous system functioning'
[patent_app_type] => utility
[patent_app_number] => 12/778006
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 4807
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12778006
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778006 | Methods of improving central nervous system functioning | May 10, 2010 | Issued |
Array
(
[id] => 8270191
[patent_doc_number] => 08211695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 12/751718
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4234
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751718
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/751718 | Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders | Mar 30, 2010 | Issued |
Array
(
[id] => 6070097
[patent_doc_number] => 20110044947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'METHODS OF TREATING CARDIAC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/731550
[patent_app_country] => US
[patent_app_date] => 2010-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12059
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12731550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/731550 | METHODS OF TREATING CARDIAC DISORDERS | Mar 24, 2010 | Abandoned |
Array
(
[id] => 9112896
[patent_doc_number] => 08569065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Compositions and methods for the delivery of biologically active RNAs'
[patent_app_type] => utility
[patent_app_number] => 12/724408
[patent_app_country] => US
[patent_app_date] => 2010-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 60847
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12724408
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724408 | Compositions and methods for the delivery of biologically active RNAs | Mar 14, 2010 | Issued |
Array
(
[id] => 6482343
[patent_doc_number] => 20100192239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Modulation of Mu Delta Opioid Receptor Expression'
[patent_app_type] => utility
[patent_app_number] => 12/695676
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6848
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20100192239.pdf
[firstpage_image] =>[orig_patent_app_number] => 12695676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/695676 | Modulation of Mu Delta Opioid Receptor Expression | Jan 27, 2010 | Abandoned |
| 12/657242 | COMPOSITIONS FOR REGENERATION AND REPAIR OF CARTILAGE LESIONS | Jan 14, 2010 | Abandoned |
Array
(
[id] => 4490926
[patent_doc_number] => 07955595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-07
[patent_title] => 'Glutamic acid decarboxylase (GAD) based delivery system'
[patent_app_type] => utility
[patent_app_number] => 12/685385
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 45
[patent_no_of_words] => 28566
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/955/07955595.pdf
[firstpage_image] =>[orig_patent_app_number] => 12685385
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685385 | Glutamic acid decarboxylase (GAD) based delivery system | Jan 10, 2010 | Issued |
Array
(
[id] => 6567309
[patent_doc_number] => 20100223685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'IL-21 RECEPTOR KNOCKOUT ANIMAL AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/683117
[patent_app_country] => US
[patent_app_date] => 2010-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15150
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20100223685.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683117
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683117 | IL-21 RECEPTOR KNOCKOUT ANIMAL AND METHODS OF USE THEREOF | Jan 5, 2010 | Abandoned |
Array
(
[id] => 5961055
[patent_doc_number] => 20110185442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'Method of generating transgenic organisms using transposons'
[patent_app_type] => utility
[patent_app_number] => 12/655114
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11468
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20110185442.pdf
[firstpage_image] =>[orig_patent_app_number] => 12655114
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655114 | Method of generating transgenic organisms using transposons | Dec 22, 2009 | Abandoned |
Array
(
[id] => 6539834
[patent_doc_number] => 20100287627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Transgenic Zebrafish Models for Neurodegenerative Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/646083
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13819
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20100287627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12646083
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/646083 | Transgenic Zebrafish Models for Neurodegenerative Diseases | Dec 22, 2009 | Abandoned |
Array
(
[id] => 6317392
[patent_doc_number] => 20100112659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'FERMENTATION PROCESS'
[patent_app_type] => utility
[patent_app_number] => 12/644836
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6136
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112659.pdf
[firstpage_image] =>[orig_patent_app_number] => 12644836
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644836 | FERMENTATION PROCESS | Dec 21, 2009 | Abandoned |
Array
(
[id] => 6282066
[patent_doc_number] => 20100257616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/653904
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 45705
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20100257616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653904 | DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof | Dec 17, 2009 | Abandoned |
Array
(
[id] => 6079965
[patent_doc_number] => 20110142811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/639536
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5659
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12639536
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/639536 | MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS | Dec 15, 2009 | Abandoned |
Array
(
[id] => 6423855
[patent_doc_number] => 20100168022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens'
[patent_app_type] => utility
[patent_app_number] => 12/636214
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9075
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12636214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/636214 | Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens | Dec 10, 2009 | Abandoned |
Array
(
[id] => 6302041
[patent_doc_number] => 20100068148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'ENHANCED RESOLUTION OF TUMOR METASTASIS USING A SKIN FLAP MODEL'
[patent_app_type] => utility
[patent_app_number] => 12/622389
[patent_app_country] => US
[patent_app_date] => 2009-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3947
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068148.pdf
[firstpage_image] =>[orig_patent_app_number] => 12622389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/622389 | ENHANCED RESOLUTION OF TUMOR METASTASIS USING A SKIN FLAP MODEL | Nov 18, 2009 | Abandoned |
Array
(
[id] => 6567248
[patent_doc_number] => 20100223681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Assessment Method'
[patent_app_type] => utility
[patent_app_number] => 12/610741
[patent_app_country] => US
[patent_app_date] => 2009-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4731
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20100223681.pdf
[firstpage_image] =>[orig_patent_app_number] => 12610741
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/610741 | Assessment Method | Nov 1, 2009 | Abandoned |
Array
(
[id] => 7523190
[patent_doc_number] => 08026346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Tribonectins'
[patent_app_type] => utility
[patent_app_number] => 12/608462
[patent_app_country] => US
[patent_app_date] => 2009-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9701
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026346.pdf
[firstpage_image] =>[orig_patent_app_number] => 12608462
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/608462 | Tribonectins | Oct 28, 2009 | Issued |
Array
(
[id] => 6204334
[patent_doc_number] => 20110067120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Iduronidase knock-out mouse'
[patent_app_type] => utility
[patent_app_number] => 12/585544
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3067
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20110067120.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585544 | Iduronidase knock-out mouse | Sep 16, 2009 | Issued |
Array
(
[id] => 6466917
[patent_doc_number] => 20100040586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Treatment of Injuries to the Central Nervous System'
[patent_app_type] => utility
[patent_app_number] => 12/543070
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15315
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040586.pdf
[firstpage_image] =>[orig_patent_app_number] => 12543070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543070 | Treatment of Injuries to the Central Nervous System | Aug 17, 2009 | Abandoned |